Cited by 286Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 129 of the 129 references it cites were found in a registry or an index.

Locus coeruleus cellular and molecular pathology during the progression of Alzheimer’s disease

Open access
Kelly, Sarah C., He, Bin, Perez, Sylvia E., Ginsberg, Stephen D., Mufson, Elliott J., Counts, Scott E.·2017·Acta Neuropathologica Communications

Abstract

A major feature of Alzheimer's disease (AD) is the loss of noradrenergic locus coeruleus (LC) projection neurons that mediate attention, memory, and arousal. However, the extent to which the LC projection system degenerates during the initial stages of AD is still under investigation. To address this question, we performed tyrosine hydroxylase (TH) immunohistochemistry and unbiased stereology of noradrenergic LC neurons in tissue harvested postmortem from subjects who died with a clinical diagnosis of no cognitive impairment (NCI), amnestic mild cognitive impairment (aMCI, a putative prodromal AD stage), or mild/moderate AD. Stereologic estimates of total LC neuron number revealed a 30% loss during the transition from NCI to aMCI, with an additional 25% loss of LC neurons in AD. Decreases in noradrenergic LC neuron number were significantly associated with worsening antemortem global cognitive function as well as poorer performance on neuropsychological tests of episodic memory, semantic memory, working memory, perceptual speed, and visuospatial ability. Reduced LC neuron numbers were also associated with increased postmortem neuropathology. To examine the cellular and molecular pathogenic processes underlying LC neurodegeneration in aMCI, we performed single population microarray analysis. These studies revealed significant reductions in select functional classes of mRNAs regulating mitochondrial respiration, redox homeostasis, and neuritic structural plasticity in neurons accessed from both aMCI and AD subjects compared to NCI. Specific gene expression levels within these functional classes were also associated with global cognitive deterioration and neuropathological burden. Taken together, these observations suggest that noradrenergic LC cellular and molecular pathology is a prominent feature of prodromal disease that contributes to cognitive dysfunction. Moreover, they lend support to a rational basis for targeting LC neuroprotection as a disease modifying strategy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s40478-017-0411-2

Cites

129 of 129 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 LC cell loss in aMCI. a Representative TH-ir neuron and fiber staining in dorsal pontine tissue harvested from NCI, aMCI, and mild/moderate AD subjects. b Unbiased stereological cell counts revealed a significant ~30% decrease in the number of LC neurons in aMCI compared to NCI cases. There was a ~50% loss of LC neurons in the AD group compared to NCI. **, p < 0.01, ***, p < 0.001 compared to NCI, via one-way ANOVA with Bonferroni post hoc testing. There was also a significant ~25% difference in neuronal cell counts between the aMCI and AD groups (p < 0.05). me5 = mesencephalic tract of 5. Scale Bar = 100 μm
Fig. 1 LC cell loss in aMCI. a Representative TH-ir neuron and fiber staining in dorsal pontine tissue harvested from NCI, aMCI, and mild/moderate AD subjects. b Unbiased stereological cell counts revealed a significant ~30% decrease in the number of LC neurons in aMCI compared to NCI cases. There was a ~50% loss of LC neurons in the AD group compared to NCI. **, p < 0.01, ***, p < 0.001 compared to NCI, via one-way ANOVA with Bonferroni post hoc testing. There was also a significant ~25% difference in neuronal cell counts between the aMCI and AD groups (p < 0.05). me5 = mesencephalic tract of 5. Scale Bar = 100 μmCC BY · PubMed Central
Fig. 2 TH-ir LC neuron number correlates with multiple measures of antemortem cognition and postmortem neuropathology during the progression of AD. Scatterplots show significant relationships between reductions in LC neurons and a the GCS for each individual (r = 0.7, p < 0.0001), as well as poorer performance on composite scores of b episodic memory (r = 0.71, p < 0.0001), c semantic memory (r = 0.598, p = 0.0008), d working memory (r = 0.6, p = 0.0006), e perceptual speed (r = 0.66, p < 0.0001), and f visuospatial ability (r = 0.53, p = 0.003). There were also significant negative correlations between TH+ neuron number and increasing neuropathology as defined by g Braak (r = −0.46, p = 0.01), h CERAD (r = −0.41, p = 0.03), and i NIA-Reagan (r = −0.45, p = 0.01) diagnostic criteria. All associations were tested using Spearman rank correlation analysis. Abbreviations: TH+ (TH-positive), POSS. (possible), PROB. (probable), DEF. (definite), INT. (intermediate). Symbols: NCI (blue-filled circle), aMCI (green-filled circle), AD (red-filled circle)
Fig. 2 TH-ir LC neuron number correlates with multiple measures of antemortem cognition and postmortem neuropathology during the progression of AD. Scatterplots show significant relationships between reductions in LC neurons and a the GCS for each individual (r = 0.7, p < 0.0001), as well as poorer performance on composite scores of b episodic memory (r = 0.71, p < 0.0001), c semantic memory (r = 0.598, p = 0.0008), d working memory (r = 0.6, p = 0.0006), e perceptual speed (r = 0.66, p < 0.0001), and f visuospatial ability (r = 0.53, p = 0.003). There were also significant negative correlations between TH+ neuron number and increasing neuropathology as defined by g Braak (r = −0.46, p = 0.01), h CERAD (r = −0.41, p = 0.03), and i NIA-Reagan (r = −0.45, p = 0.01) diagnostic criteria. All associations were tested using Spearman rank correlation analysis. Abbreviations: TH+ (TH-positive), POSS. (possible), PROB. (probable), DEF. (definite), INT. (intermediate). Symbols: NCI (blue-filled circle), aMCI (green-filled circle), AD (red-filled circle)CC BY · PubMed Central
Fig. 3 Single LC neuron expression profiling reveals alterations in mRNAs regulating mitochondrial and neuritic function during AD progression. a Primary custom microarray data showing hybridization signal intensities of select mRNA transcripts within TH-ir LC neurons in NCI and aMCI. Abbreviations: cytochrome C1 (Cytc1), glutathione peroxidase (Gpx1), glucose transporter 3 (Glut3), phosphofructokinase-liver isozyme (Pfkl), microtubule associated binding protein 1a (Map1a), and neurofilament heavy (Nfh), medium (Nfm), or light (Nfl) chain subunits. b Heatmap shows significant decreases in transcripts regulating mitochondrial fucntion in LC neurons in aMCI and AD cases compared to NCI, including Cytc1, nuclear respiratory factor 1 (Nrf1), superoxide dismutase 2 (Sod2) and Gpx1, whereas Pfkl and platelet (Pfkp) isozymes were up-regulated in mild AD (red to green = decreasing expression levels). Additional abbreviations: superoxide dismutase 1 (Sod1), glutathione transferase (Gst), cytochrome p450 11a (Cyp11a), and pfk-muscle (Pfkm). c Heatmap shows significant decreases in transcripts regulating cytoskeletal/structural plasticity in LC neurons in aMCI and AD cases compared to NCI, including Map1b, Nfh, integrin 3 (Itga3), netrin 1 (Ntn1), utrophin (Utrn), and synaptopodin (Synpo), whereas calpain 1 (Capn1, m-calpain) and calpain 2 (Capn2, μ-calpain) were up-regulated in mild AD (red to green = decreasing expression levels). Additional mRNAs: mitochondrial associated protein 2 (Map2), and synaptojanin (Synj). a, NCI > aMCI, AD, p < 0.01; b, NCI > aMCI, AD, p < 0.001; c, AD > NCI, aMCI, p < 0.01
Fig. 3 Single LC neuron expression profiling reveals alterations in mRNAs regulating mitochondrial and neuritic function during AD progression. a Primary custom microarray data showing hybridization signal intensities of select mRNA transcripts within TH-ir LC neurons in NCI and aMCI. Abbreviations: cytochrome C1 (Cytc1), glutathione peroxidase (Gpx1), glucose transporter 3 (Glut3), phosphofructokinase-liver isozyme (Pfkl), microtubule associated binding protein 1a (Map1a), and neurofilament heavy (Nfh), medium (Nfm), or light (Nfl) chain subunits. b Heatmap shows significant decreases in transcripts regulating mitochondrial fucntion in LC neurons in aMCI and AD cases compared to NCI, including Cytc1, nuclear respiratory factor 1 (Nrf1), superoxide dismutase 2 (Sod2) and Gpx1, whereas Pfkl and platelet (Pfkp) isozymes were up-regulated in mild AD (red to green = decreasing expression levels). Additional abbreviations: superoxide dismutase 1 (Sod1), glutathione transferase (Gst), cytochrome p450 11a (Cyp11a), and pfk-muscle (Pfkm). c Heatmap shows significant decreases in transcripts regulating cytoskeletal/structural plasticity in LC neurons in aMCI and AD cases compared to NCI, including Map1b, Nfh, integrin 3 (Itga3), netrin 1 (Ntn1), utrophin (Utrn), and synaptopodin (Synpo), whereas calpain 1 (Capn1, m-calpain) and calpain 2 (Capn2, μ-calpain) were up-regulated in mild AD (red to green = decreasing expression levels). Additional mRNAs: mitochondrial associated protein 2 (Map2), and synaptojanin (Synj). a, NCI > aMCI, AD, p < 0.01; b, NCI > aMCI, AD, p < 0.001; c, AD > NCI, aMCI, p < 0.01CC BY · PubMed Central
Fig. 4 Alterations in select transcripts isolated from noradrenergic LC neurons correlate with global cognition during the progression of AD. Scatterplots show significant relationships between decreasing levels of a Cytc1 (r = 0.64, p < 0.0001), b Nrf1 (r = 0.57, p = 0.0003), c Map1b (r = 0.59, p = 0.0006), and d Synpo (r = 0.65, p < 0.0001) and worsening GCS score, via Spearman rank correlation analysis. Symbols: NCI (blue-filled circle), aMCI (green-filled circle), AD (red-filled circle)
Fig. 4 Alterations in select transcripts isolated from noradrenergic LC neurons correlate with global cognition during the progression of AD. Scatterplots show significant relationships between decreasing levels of a Cytc1 (r = 0.64, p < 0.0001), b Nrf1 (r = 0.57, p = 0.0003), c Map1b (r = 0.59, p = 0.0006), and d Synpo (r = 0.65, p < 0.0001) and worsening GCS score, via Spearman rank correlation analysis. Symbols: NCI (blue-filled circle), aMCI (green-filled circle), AD (red-filled circle)CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

Sorted by citations

See all 286

Metadata

Authors
Kelly, S. C., He, B., Perez, S. E., Ginsberg, S. D., Mufson, E. J., & Counts, S. E.
Affiliations
  • Michigan State University (US)
  • Barrow Neurological Institute (US)
  • Nathan Kline Institute for Psychiatric Research (US)
  • Trinity Health Grand Rapids (US)
Corresponding author
Counts, Scott E.
Venue
Acta Neuropathologica Communications
Published
2017-01-21
Volume
5
Issue
1
Pages
8-8
ISSN
2051-5960 (ISSN-L)
OpenAlex
W2579788133
Cited by
286
References
129
Citations by year
2026: 22 · 2025: 28 · 2024: 41 · 2023: 35 · 2022: 34 · 2021: 48 · 2020: 27 · 2019: 26 · 2018: 12 · 2017: 12
FWCI
15.57
Type
journal article
Language
en
Open access
Locations
  • Acta Neuropathologica Communications (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • National Institute on Aging (AG043375, AG042146)
  • Saint Mary's Foundation
  • Barrow and Beyond
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
Alzheimer's disease, locus coeruleus, noradrenergic neurons, neuronal loss, amnestic mild cognitive impairment, prodromal Alzheimer's disease, tyrosine hydroxylase, stereology, gene expression, mitochondrial respiration, redox homeostasis, cognitive decline, postmortem neuropathology, neuroprotection
MeSH terms
Aged, Aged, 80 and over, Alzheimer Disease, Cell Count, Female, Humans, Immunohistochemistry, Locus Coeruleus, Longitudinal Studies, Male, Neurons, Neuropsychological Tests, RNA, Messenger, Tyrosine 3-Monooxygenase, Gene Expression, Disease Progression, Microarray Analysis, Cognitive Dysfunction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review